Is a
Patent attributes
Patent Applicant
Current Assignee
0
Patent Jurisdiction
Patent Number
Patent Inventor Names
Maria Taddei0
Hiten Gutka0
Jessica Cheung0
Date of Patent
March 29, 2022
0Patent Application Number
160729910
Date Filed
February 1, 2017
0Patent Citations
Patent Primary Examiner
The disclosure provides buffered formulations of adalimumab. The formulations comprise a buffer comprising an acetate salt, sorbitol, histidine and/or a histidine salt and optionally arginie and/or an arginine salt, and polysorbate 80. The formulations have an acidic pH, and enhance the thermal, conformational and colloidal stability of antibodies, including the adalimumab antibody.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
